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Writing this 5th year thesis has offered several challenges along the way. The first one came as 
early as the fall of 2011, when I as a 4th year student had to choose a topic to write about, find 
someone who was willing to supervise and submit a project plan to the faculty. I was leaving 
for Australia for an exchange semester that fall, thus I was in a bit of a hurry. The paperwork 
for approval of the 5th year thesis had to be submitted before departure. I was relieved when 
professor Eyvind Paulssen, MD, PhD, contacted me and suggested that I could write a report 
on irritable bowel syndrome with data retrieved from the Tromsø survey; “Tromsø 6”, under 
his supervision. I gladly accepted his proposition, which has resulted in the following paper.  
We hit a few bumps in the road early on when applying for extraction of data from the Tromsø 
survey. The survey committee turned us down a couple of times, due to overlap with another 
research project who aimed report on similar topics with the same set of data we were 
applying for. Thus, we had to restructure and limit our project plan considerably. Initially, the 
ambition was publication in an international journal, but with the cuts we were forced to 
make, we had to lower our expectations. Our new goal became producing a solid student’s 
thesis, in which I believe we have succeeded. In working with this paper, I’ve learned that 
setbacks and disappointments are part of being a researcher. I’ve learned never to 
underestimate time expenditure in bureaucratic processes. First and foremost however, I’ve 
gotten some insight into what it takes to conduct and report an original study, which I’ll enjoy 
the next time a similar challenge arises. And this I believe is the core and purpose of the 5th 
year thesis.  
I would like to thank my mentor and supervisor on this project; Eyvind Paulssen, for his 
patience and steady guidance throughout this two year period. His assistance with statistical 
analyses in SPSS was crucial.  Also, a thank you goes out to friends and family who have 
















Objective: To study potential lifestyle and nutritional risk factors for irritable bowel 
syndrome (IBS) in an adult northern Norwegian population. In addition, report on some of the 
known risk factors for IBS in this population.  
Materials and methods: In 2007, 19 762 adults (aged 30-87) from the municipality of 
Tromsø in Northern Norway, were invited to attend a general health survey. A total of 12 984 
(65.7%) subjects accepted the invitation and answered the first visit questionnaires upon 
which this report is founded. Dietary and lifestyle, as well as some comorbidity risk factors 
for IBS were explored in a logistic regression model.  
Results: A total of 7 063 subjects (54.4%) reported having “some or more” abdominal pain or 
discomfort during the last 12 months. When applying Rome II criteria for IBS, we find a 
population prevalence of 8.4% with a female predominance and age-dependent decrease. 
Factors that influence IBS with statistical significance in a multivariate regression model were 
male gender (OR 0.55), age 50-59 years (OR 0.79), age 60-69 years (OR 0.75), age ≥70 years 
(OR 0.71), psychological/psychiatric problems (OR 1.78), hypothyroidism (OR 1.37), 
exercising more than 4 hours per week (OR 0.79), eating breakfast daily (OR 1.33) and 
drinking fruit juice daily (OR 1.24). Our model could only explained 4% of the variability of 
IBS.. Asthma, diabetes, being overweight or obese, daily coffee consumption, weekly alcohol, 
weekly fish (neither lean nor fat) and eating warm dinner more than 5 times per week, did not 
show statistical significance in affecting the variability of IBS in our model.  
Conclusion: IBS is prevalent in an urban Norwegian population. Female gender, young age, 
psychological problems, hypothyroidism, eating breakfast daily, drinking fruit juice daily are 
significant risk factors for IBS, although they explain only 4% of the variability of IBS. Male 
gender and physical activity in excess of 4 hours per week was significantly negatively 
associated with IBS.  
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Functional gastrointestinal disorders are a significant health issue amongst major parts of the 
world’s population. The term “functional” is normally applied when it is the body’s normal 
activities such as intestinal peristaltics or nervous feedback loops, which are impaired or out 
of balance. These functional disorders are today seen as idiopathic, as one cannot pinpoint 
organic causes for these functional disorders on any specific test, biomarker or imaging. 
Irritable bowel syndrome (IBS) is one such disorder. IBS is a diagnosis of exclusion used 
when patients have a certain set of gastrointestinal symptoms, but no organic findings that 
explains their symptoms. IBS comprises of chronic abdominal pain/discomfort which is 
associated with change in frequency of stool, change in form (appearance) and/or 
improvement of symptoms with defecation. In addition there are several other symptoms that 
can strengthen a presumed IBS diagnosis. For example will symptoms such as diarrhoea, 
constipation, urgency, feeling of incomplete bowel movement, passing of mucus or the feeling 
of abdominal fullness, bloating or swelling; increase suspicion towards IBS. However, these 
symptoms may also be components of organic illnesses. Because the IBS-symptoms are 
shared with many disorders, it is important to exclude other causes before diagnosing a patient 
with IBS.  
Reports on North-American populations have shown IBS frequencies of 10 to 15 percent [1-
6]. One study on a European population showed a similar result, reporting an IBS prevalence 
of 11.5 percent. The prevalence, however, varied greatly among the European countries [7]. If 
we look at different groups in a population, prevalence has been reported to be between 3% 
and 22% [8]. Younger patients and women have the highest occurrence of IBS, whilst males 
and people older than 50 years of age have a low prevalence [9]. 
IBS is associated with increased health care and welfare costs. Patients with IBS visit their 
primary physician more frequently. Many of these patients are referred to the specialized 
health care system to undergo tests such as endoscopies. IBS causes an increased burden on 
the welfare systems, as it is associated with work absenteeism, disability and increased 
consumption of pharmaceutical drugs [8, 10, 11].  
The importance of IBS as a health and socioeconomic issue makes IBS an interesting field of 
research. Our null-hypothesis was that lifestyle and nutritional habits are not risk factors for 
the development of IBS. This report aims to shed light on a selection of such factors. First, we 




In the absence of tests or clinical findings that were pathognomonic for IBS, a need for 
standardized criteria to make the diagnosis arose. Pioneering this effort were Manning and co-
workers in 1978, when they postulated a complex of symptoms indicative of IBS. Their study 
showed that four characteristics were significantly more common among patients with IBS; 
distension, onset of pain associated with looser and more frequent bowel movements, and 
relief of pain with bowel movements. Faecal mucus discharge and feeling of incomplete 
emptying were also predominant in these patients, although not significant on a 95% level 
[12]. 
To further classify functional bowel disorders and also better standardize clinical research 
protocols on the subject, authorities on gastrointestinal disorders from several countries came 
together to form what is known as the Rome Process. The different committees collaborated 
via mail and telephone until they finally met in Rome, Italy, for the defining meeting. In 1989 
came “The Rome guidelines for IBS”, that were succeeded by “the Rome I criteria for IBS” in 
1992. In 1999 the criteria were revised, and thus named “the Rome II criteria for IBS (Table 
3).” Most recent are the Rome III criteria which were published in 2006, and which are the 
current standard for diagnosis of IBS. However, these different sets of criteria have shown 
little difference in accuracy in diagnosing IBS. Therefore, some researchers still use the 
Manning criteria, Rome II, or a combination of several sets of criteria and symptoms in their 
descriptions and research of IBS. [2, 4, 12-16]. 
Pathophysiology 
Although IBS is viewed as an idiopathic disorder, numerous factors have been shown, or 
theorized to play a role in its pathophysiology. However, no abnormality has been shown to 
be specific for IBS. The idea that gastrointestinal motility abnormalities are a key factor in 
IBS has received a lot of focus. GI motor abnormalities have been detected in some patients 
with IBS, but no clear pattern has emerged that may be used as a disease marker [17-19]. 
Studies have shown that IBS patients have a high frequency of what is known as visceral 
hypersensitivity. The hypothesis behind this is that receptors of the afferent nerves in the gut 
wall are hypersensitive to stimulation such as distention or bloating [20-23]. It is unclear 
whether this observed sensitivity increase is mediated by the local enteric nervous system, by 




Immunohistological studies have shown some patients with IBS to have increased activation 
of the mucosal immune system characterized by altered immune cell numbers and markers in 
the gut wall [29-34]. One study looked at tissue samples from the jejunum in 10 patients with 
severe IBS. They found low-grade infiltration of lymphocytes in the myenteric plexus in all 
but one patient, and neuron degeneration in 7 out of 10 patients [30, 34]. The immune cells 
secrete inflammatory cytokines that might play a role in IBS. Increase in gut wall immune cell 
activity is mainly seen in patients with so called “diarrhoea-predominant” IBS and patients 
with presumed post-infectious IBS [29-34]. 
The suspicion that the development of IBS is linked to GI-infections remains strong. 
Clinicians have observed occurrence of irritable bowel symptoms following GI-infections 
with acute diarrhoea. The infectious agents causing enteritis may be bacteria, protozoa, 
helminths or viruses [35-38]. The cause of IBS-symptoms following infection, i.e. post-
infectious IBS, is unknown but theories are many. Development of bile acid malabsorption 
post infection is one [39, 40]. Increased number of serotonin-containing enteroendocrine cells 
and T-lymphocytes, another, with increased serotonin levels resulting in increased GI-motility 
and visceral hypersensitivity [41]. A third possibility that has been observed as a risk factor in 
developing post-infectious IBS is the use of antibiotics to treat the infection [42, 43]. Also 
longer duration of infection, young age, prolonged fever, anxiety, and depression have been 
proposed as risk factors for developing post-infectious IBS [37, 44].  
Studies suggest that a disturbance in faecal microflora predisposes for IBS, and that the faecal 
microbiota in patients with IBS differs with the predominant symptoms [45-49]. One might 
deduce that these patients would benefit from probiotics; however studies have not shown a 
significant effect on the intestinal flora of patients with IBS when given Lactobacillus 
plantarum [50]. Faecal microbiota transplantation (FMT) is thought to have better effect than 
prepared probiotics. Although treatment of recurrent Clostridium difficile infections with FMT 
is well established, there are currently no large studies on effects of FMT on IBS patients [51].  
Investigations into a possible association between small intestinal bacterial overgrowth and 
IBS have shown conflicting results [52-58].  
The role of food sensitivity and food allergy has received a lot of focus in research of IBS. 
There has been no clear resolve as to the role of food in IBS’ pathophysiology. It is however 
without doubt that some IBS patients have a perceived intolerance to some foods, and 
experience a flare in symptoms after ingesting these foods [59, 60]. Studies have focused on 
food-specific antibodies, carbohydrate malabsorption and gluten sensitivity.  
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Some studies have shown that eliminating specific foods in patients who have elevated IgG 
titres associated with the same food antigens, may reduce IBS symptoms [61, 62]. One study 
also showed that IBS patients had a greater number of positive skin-prick tests compared to 
controls [63]. Though, in another study, patients were challenged with the foods that caused 
positive skin prick tests, and did not show exacerbation of symptoms [64].  
The importance of carbohydrate malabsorption in IBS is still under investigation. However, 
the theory is that oligo-, di-, and monosaccharides and polyols (e.g. sugar alcohols) pass to the 
ileum and proximal colon, where they are fermented, causing symptoms, increased intestinal 
permeability and possibly inflammation [65].  
Lactose intolerance has a symptom pattern similar to that of IBS and should therefore be 
explored as a differential diagnosis in patients with functional bowel symptoms.  
Fructose intolerance is suggested to be a contributor to bothersome GI symptoms such as 
flatulence, pain and altered bowel habits [66]. A small controlled trial found that dietary 
restriction of fructose gave relief of symptoms in IBS patients selected because of prior 
response to dietary change [67]. With this in mind, we have included an analysis of fruit-juice 
intake as a possible risk factor for IBS in this study.  
Studies suggest some overlap between celiac disease and IBS [68, 69]. Some IBS patients 
with genetic predisposition to celiac disease, but with no villous atrophy, may respond to a 
gluten free diet [70]. Still, celiac disease should be excluded prior to diagnosing a patient with 
serologic test suggestive of celiac disease, with IBS.  
The genetic influence on developing IBS is still being explored. Twin- and familial studies 
have suggested a genetic predisposition to IBS between affected parents and their offspring, 
although not definitive, as social factors were suggested as the stronger predictor in the 
familial nature of IBS in some studies [71-75]. 
IBS and mental health problems have been viewed as closely linked for as long as the 
diagnosis has existed. IBS patients show higher levels of daily stress, depression, anxiety, 
phobias and somatization [76, 77]. In another study, psychosocial factors such as anxiety, 
sleep problems and somatic symptoms were shown to be independent risk factors for IBS in a 




As one does not know the aetiology of IBS, no specific treatment regimen exists. The first 
line of treatment for patients with mild or moderate types of IBS is exploration of possible 
dietary or behavioural triggers.  Use of pharmacologic therapy is often aimed at the 
predominant symptom in the individual patient. Some patients may benefit from an increase 
in fibre intake. Exercise has been shown to help with the symptoms of IBS [79]. Symptom 
improvement has been seen in trials with antidepressant, both TCAs and SSRIs, probably 
because of their effects on pain modulation and anticholinergic properties [80, 81]. Among 
other agents, antibiotics, antispasmodics and anti-diarrhoeals have also been investigated 
without evidence of positive long-term positive effects, although loperamide (anti-diarrhoeal) 
is found to be useful in diarrhoea-predominant IBS. In the existing studies on probiotics and 
IBS, probiotics appear ineffective in treating IBS.  
  
 
Materials and methods: 
The paper presenting the 6th Tromsø study describes it as “a population-based, prospective 
study of various health issues, symptoms and chronic diseases, and a resource for the 
surveillance of disease risk factors” [82]. The study is run and owned by the University of 
Tromsø. Six surveys have been executed so far, all collecting questionnaire data on different 
health issues as well as study site collection of physiological data and biological specimens. 
Since the fourth survey onwards, collaborative efforts between clinical and epidemiological 
researchers have influenced the study design in a larger capacity. In the most recent survey, 
“Tromsø 6” (2007-2008), at least 50 research-projects were given a say in how the 
questionnaires were designed and which biological/physiological data were to be collected 
from the participants [82]. The Clinic of Internal Medicine, Section for Gastroenterology was 
one of the groups given influence on which questions were asked. One of the areas they chose 






Tromsø is a mid-size Norwegian city with about 70 000 inhabitants within its municipality, 
from which the participants of the Tromsø survey are recruited. The city lies well north of the 
Arctic Circle at 69°N. Tromsø is the leading centre of education and health care in the most 
northern part of Norway. It houses the main hub of one of the six university hospitals in 
Norway; The University hospital of North Norway. Tromsø is also a centre of research 
(medical and other), administration and fishing related activities. The population consists 
mainly of Caucasians of Norwegian origin [82].  
The Tromsø 6 study was executed between October 2007 and December 2008. The following 
groups were invited to the first visit which included the two questionnaires upon which this 
report is founded:  
 All participants who attended the second visit of the Tromsø 4 survey (1994-5).  
 A 10% random sample of the Tromsø population aged 30-39.  
 A 40% random sample of those aged 43-59.  
 All residents aged 40-42 and 60-87 [79].  
In total, 19 762 individuals were invited, out of these, 12 984 subjects responded and 
participated in the first visit examinations. That makes a study participation rate of 65.7%. 











Distribution of genders 
 Frequency Proportion 
Female 6928 53.4% 
Male 6053 4.6% 
Total 12981 100% 
Table 1: Distribution of genders 
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The first questionnaire (Q1) was filled in at home by the participants prior to the first visit, 
where they were issued the second, and more extensive (28 page) questionnaire (Q2). The Q2 
was by most attendants filled in at the study site, although some participants were issued an 
envelope and given the option to fill in the Q2 at home and return it by mail. We will not be 
describing in detail the other tests and data collected from either the first or second study visit. 
Tests like forearm bone density, pain sensitivity, blood-tests, hip/waist ratio and nose/throat 
swabs were performed during the first visit. Those invited to the second visit went through 
cognitive tests, right carotid ultrasound, retinal imaging, spirometry and more [82]. These 
tests are not included in our report. However, it should be mentioned that none of the tests 
performed were focused directly on GI symptoms or disease. Therefore, these should not be 
contributors to a higher rate of self-selection bias amongst the participants with respect to GI 
symptoms or disease.  
Distribution of age-groups 
Age Frequency Proportion 
30-39 yrs 509 3.9% 
40-49 yrs 3574 27.5% 
50-59 yrs 2436 18.8% 
60-69 yrs 4102 31.5% 
>70 yrs 2360 18.2% 
Total 12981 100% 
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The questions used as data for this report are listed in Appendix 1. As mentioned earlier, we 
chose to apply a strict IBS definition according to the Rome II criteria (Table 3) for IBS, 
which were the norm for diagnosis of IBS when the questionnaires for Tromsø 6 were made. 
Firstly, we selected those who answered “some or more” to one or more of alternative #3-7 on 
question 4.16. They were defined as having abdominal pain or discomfort during the last 12 
months. A positive answer on alternative #2 of question 4.17 fulfilled the criteria of “at least 
12 weeks during the last year of abdominal pain or discomfort.” Furthermore, alternatives #3, 
4 and 5 of question 4.17 are quite accurate in describing the three features of which the 
participants needed to fulfil two out of three, to receive the IBS diagnosis. To summarize, the 
combination “some or more” on 4.16 alternatives #3-7, “Yes” on question 4.17’s alternative 
#2 and “Yes” on at least two out of the three alternatives #3-5 of question 4.17, was defined as 
a positive IBS diagnosis in this report.  
 Table 3: Rome II diagnostic criteria for irritable bowel syndrome 
Statistical analysis  
As presented in Appendix 1, the variables/questions answered by the participants were of 
categorical, continuous, and binary nature. For simpler analysis, we chose to dichotomise the 
categorical and continuous data concerning dietary habits and exercise into binary data. The 
variables that were dichotomised may be viewed in Appendix 2.  
All descriptive and inferential statistics were generated using SPSS statistics software version 
19 (IBM Corporation, Armonk, NY, USA). The statistical significance of the potential risk 
factor’s association to IBS was assessed using binomial logistic regression (forced entry). 
Comparisons of the differences between groups were measured using Chi-square test. Results 
are presented as odds ratio with 95% confidence intervals and p-values to complement them. 
Statistical significance was accepted where p-values less than 0.05. Variables that in the 
univariate analyses had p-values <0.20, were included in the multivariate model [83]. 
Goodness-of-fit of our logistic regression model was estimated with Nagelkerke’s R2. 
Rome II diagnostic criteria for irritable bowel syndrome 
At least 12 weeks, which need not be consecutive,   
in the preceding 12 months of abdominal discomfort or pain that has two out of three 
features 
1. Relieved with defecation; and/or 
2. Onset associated with a change in frequency  
of stool; and/or 





This project was granted the use of questionnaire data from Tromsø 6 by the Tromsø Survey 
Committee. Tromsø 6 is a wide scoped prospective population study as described above. All 
participants gave written informed consent prior to enrolment in the survey [82].  
  
Results 
The youngest and the oldest invitees were the worst responders, especially the youngest men. 
The mean age of the participants was 57.5 years for the females and 57.5 years for the males. 
There was no significant difference in age between the sexes when tested with the Student’s t-
test, p= 0.915.  
Of all invited subjects, 12 984 responded to the survey’s first visit questionnaires. More than 
half of these, 7 063 (54.4%) of reported to have “some or more” abdominal pain or discomfort 
during the last 12 months, whereas 2 610 (20.1%) did not answer this question, and 3 308 
(25.5%) had no abdominal discomfort.  
After applying our previously mentioned IBS definition, which coincides quite accurately 
with the Rome II criteria, we found the prevalence of irritable bowel syndrome to be 8.4% 
(Table 4).  
We evaluated the potential risk factors that we wanted to look at, in a logistic regression 
model. Risk factors for IBS which showed statistical significance were female gender, young 
age (<50 years), psychological/psychiatric problems, hypothyroidism, living a sedentary life 
(exercise less than 4 h/week), eating breakfast daily and drinking fruit juice daily. Risk factors 
that were significant as an individual factor, but failed to hold up in the final model, were 
asthma and eating fat fish less than once a week. Factors that did not reach statistical 
significance were excessive BMI, diabetes mellitus, eating warm dinner less than five days a 
week, eating lean fish less than once a week, daily coffee consumption of any type and 
weekly alcohol consumption. These results are presented in Table 5. Our model could only 






IBS defined by Rome II criteria 
IBS? Frequency Percent Valid percent 
No 9 882 76.1% 90.1% 
Yes 1 086 8.4% 9.9% 
Total answered 10 968 84.5% 100% 
Missing 2 013 15.5%  
Total 12 981 100%  
Table 4: Frequency of IBS in the Tromsø 6 survey. 
 
Table 5: Univariate and multivariate analyses of risk factors associated with irritable bowel syndrome. 
Factors where p<0.20 in univariate analysis were included in a multivariate model (forced entry). 
Risk factors for irritable bowel syndrome according to the Rome II criteria. 
 Univariate analysis Multivariate analysis 
 OR 95% CI p-value OR 95% CI p-value 
Male gender 0.52 0.46; 0.60 <0.0005 0.55 0.47; 0.64 <0.0005 
Age group (reference 30-
49 yrs) 
      
   50-59 yrs 0.77 0.64; 0.92 0.004 0.79 0.65; 0.95 0.014 
   60-69 yrs 0.71 0.61; 0.83 <0.0005 0.75 0.62; 0.89 0.001 
   >70 yrs 0.81 0.66; 0.99 0.041 0.71 0.55; 0.93 0.013 
BMI(reference normal/ 
underweight) 
      
   Overweight 0.97 0.84; 1.11 0.64    
   Obese 1.05 0.88; 1.25 0.60    
Asthma 1.32 1.08; 1.60 0.007 1.19 0.95; 1.50 0.127 
Psychological problems 
for which you have 
sought help 
1.90 1.60; 2.27 <0.0005 1.78 1.47; 2.17 <0.0005 
Hypothyroid 1.56 1.27; 1.91 <0.0005 1.37 1.08; 1.74 0.009 
Diabetes 1.30 0.97; 1.71 0.063 1.14 0.97; 1.88 0.80 
Exercise >4h/w 0.73 0.63; 0.85 <0.0005 0.79 0.67; 0.94 0.009 
Warm dinner >5x/w 0.87 0.68; 1.10 0.23    
Lean fish >1x/w 0.98 0.85; 1.12 0.74    
Fat fish >1x/w 0.88 0.77; 0.99 0.048 0.89 0.77; 1.03 0.126 
Fish total >1x/w??       
Daily breakfast 1.16 0.94; 1.44 0.17 1.33 1.04; 1.70 0.024 
Coffee filtered daily 0.94 0.81; 1.10 0.47    
Coffee boiled daily 0.95 0.81; 1.11 0.54    
Coffee other daily 1.02 0.86; 1.20 0.82    
Coffee any type daily 0.82 0.65; 1.03 0.09 0.95 0.74; 1.23 0.714 
Alcohol weekly 0.86 0.74; 1.01 0.058 0.94 0.79; 1.12 0.496 
Juice daily 1.20 1.05; 1.38 0.008 1.24 1.07; 1.44 0.006 




The purpose of our study was to assess potential lifestyle and nutritional risk factors for IBS, 
which have not been reported on to extent previously. In addition, we wanted to report on 
some of the known risk factors for IBS as well as descriptive statistics for IBS in the Tromsø 
population.  
There was no significant difference in age between sexes among the participants. When taken 
into consideration that about half of the participants were over the age of 60 years old, one 
would think that there would be a significantly higher proportion of women, as women have a 
longer life expectancy [84]. 
The Tromsø 6 survey’s first visit had a participation rate of 65.7%. This is comparable to, and 
somewhat higher than the trends for similar surveys have been showing in recent years [85-
89].  
A fifth of the participants did not answer question 4.16 about abdominal symptoms. These 
non-responders might feel that the question was not relevant to them; they did not understand 
the question, or maybe they perceived the information to be too private. If these subjects are 
different as a group compared to the responders, we might have a case of “item non-response” 
bias. If these non-responders were to be significantly younger-, older, or skewed towards one 
gender, this could be relevant to our results. However, we have chosen not to explore this 
possible bias further.  
Our definition of IBS was adapted as best we could to the Rome II criteria from the available 
data. The question that attended to the time aspect of the Rome II criteria of “recurrent 
abdominal pain or discomfort at least 3 days per month in the last three months;” read: “If 
you, during the last year, have had abdominal pain or discomfort, were you bothered as often 
as once a week or more during the last 3 months (Appendix 1)?” Abdominal symptoms at 
least once a week, would reasonably account to at least 4 days of symptoms per month. In that 
sense, our definition might exclude patients with a slightly milder symptom load, who would 
still fulfil the Rome II criteria for IBS. However, this should lead to a rather conservative 
estimate of IBS occurrence on our part, and we believe the phrasings of the bowel function 




We found the prevalence of IBS in this population sample from the city of Tromsø, northern 
Norway, to be 8.4%. This is comparable to, and somewhat lower than reports from other 
western populations [5, 8, 9]. Exactly the same prevalence (8.4%) was found by another 
Norwegian study from 2006 [90]. This study was based on a public health survey carried out 
in Oppland which is a county inland in Southern Norway. They measured the occurrence of 
IBS in adults aged 30-75 through questionnaires based on the Rome II criteria. This suggests 
that there might be little difference in IBS prevalence between the Northern and Southern 
parts Norway. A study from Vietnam by Zuckerman et al. (2006) showed a prevalence of IBS 
of 7.2%, using Rome I criteria [91]. Lovell et al. recently (2012) published a review article on 
global IBS prevalence, in which they did a large meta-analysis of 81 prevalence reports from 
80 different populations. They found the global pooled prevalence of IBS to be 9.4%, when 
applying the Rome II criteria. They found that the frequency was higher when applying the 
Manning criteria (14%), and lower when using the Rome I criteria (8.8%) [9].  
The strengths of this study lies in the number of participants and the fact that it is a part of a 
general health survey. For this reason, we assume that there is no self-selection bias for 
functional bowel symptoms or disease, corrupting our results. We have dichotomised ordinal- 
and continuous data (e.g. consummation of coffee, alcohol, exercise, abdominal pain or 
discomfort, fish eating and warm dinner) for the purpose of simplifying statistical analysis 
and presentation. However, this technique may have caused loss of information and 
compromised the statistical power of our model in predicting IBS. Also, we risked residual 
confounding by the same factors that we aim to adjust for [92, 93]. Analyses have not been 
performed to find “optimal” cut- off points to skew the results in our favour. The cut-off 
points are rather based solely on common sense. It should be emphasized that many of the 
variables applied in the model were already binary (e.g. diabetes, hypothyreosis, asthma, 
breakfast daily). 
In this report, we have large dataset and a binary outcome measure (IBS yes or no). Our 
predictor variables do not behave in an ordinal way. For these reasons, a binomial logistic 




We confirm the findings from previous reports; that female gender, psychological problems 
and young age (<50), are significant risk factors for IBS [9, 76-78, 83, 90, 95]. The positive 
association of daily fruit juice consumption with IBS is supported by several studies 
implicating the role of fructose intolerance as part of the aetiology of IBS [66, 67, 96, 97]. 
One study of IBS in relation to exercise showed that physical activity may improve IBS 
symptoms in IBS patients [79]. We find that at least 4 hours a week of physical activity 
significantly lowers the risk of IBS.  
Asthma may be applied as a marker for atopy i.e. proneness to hypersensitivity towards 
allergens and/or pollutants. This may include food intolerance and food allergies. Therefore, 
we found it useful to include asthma in our regression model. Asthma was a significant risk 
factor/comorbidity when tested solely against IBS, but did not reach significance in the final 
multivariate model (p=0.127).  
We found that hypothyroidism was a significant risk factor for IBS. This result was a 
somewhat surprising as there are no previous studies reporting low metabolism as a risk factor 
for IBS. One might argue the fact that more women have both IBS and hypothyroidism, but 
this possible confounder should be adjusted for in our model. However, the way the question 
is phrased; “Have you, or have you ever had low metabolism,” might be misinterpreted by 
some participants as something other than a measured low thyroxin level, causing an 
overestimate of the occurrence of hypothyroidism in our study. About 10 per cent of the 
survey participants reported having low metabolism. One study from the United States 
showed the prevalence of hypothyroidism (including subclinical) to be 4.6% [98]. Other 
studies have shown varying prevalence of overt hypothyroidism of 0.1 to 2.0%[99-102].  
The most contra-intuitive result we found was that the daily breakfast eaters actually had a 
significantly higher risk of developing IBS. People that eat breakfast daily are often 
considered to be more structured, healthier and more conscious about their eating habits than 
the breakfast skippers. Thus we expected daily breakfast to be a negative predictor of IBS. It 
is hard to say what the reason for the opposite result might be. Our model adjusts for daily 
intake of fruit juice which could have been a confounder to this result, since fruit juice often is 
consumed with breakfast. The breakfast eaters may be consuming more fresh fruit. The first 
meal of the day is also associated with lactose containing foods, especially milk. Our model 




Diabetes mellitus and excessive BMI did not reach significance as risk factors for IBS in our 
study. This is in accordance with previous studies, although one study showed significance for 
functional bowel symptoms among the obese [83]. Being overweight is more associated with 
upper GI symptoms, such as gastro-oesophageal reflux disease (GORD). [103-105]. 
None of the dietary factors we tested, except for fruit juice, came out significant in our final 
analysis. Eating fat fish less than once a week was a significant risk factor in the univariate 
analysis, but fell short when we adjusted for age, sex and all the other variables in the final 
model. We dichotomised the coffee drinkers into two groups: the ones that drink no coffee at 
all in one group and those who drink 1 cup or more in the other group. Perhaps more 
distinctive results could be found if we had divided the coffee drinkers into a few more 
categories so that we could look at the subjects who drank a small-, moderate and large 
amount of cups per day. 
We conclude that some nutritional and lifestyle habits are associated with the complicated 
picture that is IBS, although they explain only a small proportion of its variability and appears 
to be weak predictors for IBS according to our model. We reject our null-hypothesis.  
 
Conclusion 
Female gender, young age, psychological problems, hypothyroidism, eating breakfast daily, 
drinking fruit juice daily are significant risk factors for IBS, although they explain only 4 per 
cent of the variability of IBS. Male gender and physical activity in excess of 4 hours per week 
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